Vasoprotective and antiatherosclerotic action of statins in patients with carotid atherosclerosis
- Authors: Belousov Y.B1, Leonova MV1, Smirnova EP1, Glezer MG1, Loshkarishvili IZ1, Masenko VP1, Tkachev GA1, Belousov Y.B1, Leonova MV1, Smirnova EP1, Glezer MG1, Loschkarischvili IZ1, Masenko VP1, Tkachev GA1
-
Affiliations:
- Issue: No 15 (2009)
- Pages: 88-94
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/278046
- ID: 278046
Cite item
Full Text
Abstract
About the authors
Yu B Belousov
M V Leonova
E P Smirnova
M G Glezer
I Z Loshkarishvili
V P Masenko
G A Tkachev
Yu B Belousov
M V Leonova
E P Smirnova
M G Glezer
I Z Loschkarischvili
V P Masenko
G A Tkachev
References
- Табеева Г.Р. Профилактика инсульта // Справочник поликлинического врача. 2006. № 3.
- Рекомендации по вторичной профилактике инсульта // Неотложная терапия. 2004. № 1-2.
- Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-89.
- Collins R, Armitage J, Parish S, et al. for the Heart Protection Study Collaborative Group. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet 2004;363:757-67.
- Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 1998;97:1440-45.
- Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol level. Results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 1998;279:1615-22.
- Yrjanheikki J, Koistinaho J, Kettunen M. Long-term protective effect of atorvastatin in permanent focal cerebral ischemia. Brain Res 2005;1052:174-79.
- Карпов Ю.А., Сорокин Е.В. Мозговые инсульты: статины эффективны для вторичной профилактики // РМЖ. 2007. Т. 14. № 20. С. 15-21.
- Парфенов В.А. Аторвастатин во вторичной профилактике ишемического инсульта // Болезни сердца и сосудов. 2006. Т. 1. № 4.
- Amarenco P, Labreuche J, Lavallee P, Touboul P-J. Statin in stroke prevention and carotid atherosclerosis: systematic review and meta-analysis. Stroke 2004;35:2902-09.
- Liao JK. Clinical implications for statin pleiotropy. Curr Opin Lipidol 2005;16:624-29.
- Switzer JA, Hess DC. Statin therapy for coronary heart disease and its effect on stroke. Curr Atheroscler Rep 2006;8:337-42.
- Szapary L, Horvath B, Marton Z, et al. Short-term effect of low-dose atorvastatin on haemorrheological parameters, platelet aggregation and endothelial function in patients with cerebrovascular disease and hyperlipidaemia. CNS Drugs 2004;18:165-72.
- Stoll G, Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke 2006;37:1923-32.
- Minoguchi K, Yokoe T, Tazaki T, Minoguchi H. et al. Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Resp Critical Care Med 2005;172:625-30.
- Bots ML. IL-6, carotid plaques predict mortality in elderly. Am J Med 2006;119:519-25.
- Ridker PM, Cannon CP, Morrow D, et al. for the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators C-Reactive Protein Levels and Outcomes after Statin Therapy. N Eng J Med 2005;352:20-28.
- Смирнова Е.П., Леонова М.В., Белоусов Ю.Б. и др. Вазопротективное и антиатерогенное действие комбинации аторвастатина и клопидогреля у больных каротидным атеросклерозом // Фарматека. 2007. № 19. С. 64-67.
- http://www.pharmateca.ru/cgi-bin/statyi.pl?sid=2411&mid=1085056570&magid=179